Novel biomarkers in cardiovascular disease: Update 2010

American Heart Journal

Volumn 160, Issue 4, 2010, Pages 583-594

  Hochholzer, Willibald ^a,b   Morrow, David A ^a   Giugliano, Robert P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLINE; COPEPTIN; CREATINE KINASE; CREATINE KINASE MB; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 15; HEART TYPE FATTY ACID BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; MYELOPEROXIDASE; MYOGLOBIN; PADGEM PROTEIN; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROADRENOMEDULLIN; SECRETORY PHOSPHOLIPASE A2; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ELECTROCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; HUMAN; INVASIVE PROCEDURE; NONSURGICAL INVASIVE THERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; METABOLISM; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 77957831897     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.010     Document Type: Review

References (97)

1. Catalona W.J., Smith D.S., and Ratliff T.L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
2. Maisel A.S., Krishnaswamy P., and Nowak R.M. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
3. Anderson J.L., Adams C.D., and Antman E.M. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction Circulation 116 2007 e148 e304
4. Goldstein D.E., Little R.R., and Lorenz R.A. Tests of glycemia in diabetes Diabetes Care 27 2004 1761 1773
5. Christenson R.H. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines for utilization of biochemical markers in acute coronary syndromes and heart failure Clin Chem 53 2007 545 546
6. Myers G.L., Christenson R.H., and Cushman M. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease Clin Chem 55 2009 378 384
7. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
8. Cowie M.R., Struthers A.D., and Wood D.A. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
9. Mueller C., Scholer A., and Laule-Kilian K. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654 (Pubitemid 38364623)
10. Felker G.M., Hasselblad V., and Hernandez A.F. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
11. Ridker P.M., Hennekens C.H., and Buring J.E. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
12. Ridker P.M., Danielson E., and Fonseca F.A. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
13. Goldhaber S.Z., Simons G.R., and Elliott C.G. Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism Jama 270 1993 2819 2822
14. Wells P.S., Anderson D.R., and Rodger M. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med 349 2003 1227 1235
15. Apple F.S., Wu A.H., and Mair J. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 2005 810 824
16. Libby P., and Theroux P. Pathophysiology of coronary artery disease Circulation 111 2005 3481 3488
17. Morrow D.A., and de Lemos J.A. Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
18. Jaffe A.S. Cardiovascular biomarkers: the state of the art in 2006 Clin Chim Acta 381 2007 9 13
19. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease: the present and the future J Am Coll Cardiol 48 2006 1 11
20. Morrow D.A., Cannon C.P., and Jesse R.L. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes Circulation 115 2007 e356 75
21. Macrae A.R., Kavsak P.A., and Lustig V. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies Clin Chem 52 2006 812 818
22. Morrow D.A., de Lemos J.A., and Sabatine M.S. The search for a biomarker of cardiac ischemia Clin Chem 49 2003 537 539
23. Forberg J.L., Henriksen L.S., and Edenbrandt L. Direct hospital costs of chest pain patients attending the emergency department: a retrospective study BMC Emerg Med 6 2006 6
24. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard Clin Chem 55 2009 1303 1306
25. Apple F.S., Jesse R.L., and Newby L.K. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes Clin Chem 53 2007 547 551
26. James S., Armstrong P., and Califf R. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial Am J Med 115 2003 178 184
27. Morrow D.A., Cannon C.P., and Rifai N. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial Jama 286 2001 2405 2412
28. Keller T., Zeller T., and Peetz D. Sensitive troponin I assay in early diagnosis of acute myocardial infarction N Engl J Med 361 2009 868 877
29. Reichlin T., Hochholzer W., and Bassetti S. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 2009 858 867
30. Venge P., Johnston N., and Lindahl B. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia J Am Coll Cardiol 54 2009 1165 1172
31. Wilson S.R., Sabatine M.S., and Braunwald E. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial Am Heart J 158 2009 386 391
32. Kavsak P.A., MacRae A.R., and Yerna M.J. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury Clin Chem 55 2009 573 577
33. Sabatine M.S., Morrow D.A., and de Lemos J.A. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Eur Heart J 30 2009 162 169
34. Wu A.H., and Jaffe A.S. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing Am Heart J 155 2008 208 214
35. Wu A.H., Fukushima N., and Puskas R. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector Clin Chem 52 2006 2157 2159
36. Suleiman M.S., Lucchetti V., and Caputo M. Short periods of regional ischaemia and reperfusion provoke release of troponin I from the human hearts Clin Chim Acta 284 1999 25 30
37. Remppis A., Scheffold T., and Greten J. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart J Mol Cell Cardiol 27 1995 793 803
38. Wu A.H., and Ford L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin Chim Acta 284 1999 161 174
39. Kavsak P.A., Wang X., and Ko D.T. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population Clin Chem 55 2009 1809 1815
40. Latini R., Masson S., and Anand I.S. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 2007 1242 1249
41. Schulz O., Reinicke M., and Berghoefer G.H. High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray Clin Chim Acta 411 2010 812 817
42. Kavsak P.A., Ko D.T., and Wang X. 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay Clin Chem 56 2010 487 489
43. Giannitsis E., Becker M., and Kurz K. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission Clin Chem 56 2010 642 650
44. Januzzi J.L. Jr., Bamberg F., and Lee H. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography Circulation 121 2010 1227 1234
45. Eggers K.M., Jaffe A.S., and Lind L. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making Clin Chem 55 2009 85 92
46. Hochholzer W., Buettner H.J., and Trenk D. New definition of myocardial infarction: impact on long-term mortality Am J Med 121 2008 399 405
47. Pell J.P., Simpson E., and Rodger J.C. Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study BMJ 326 2003 134 135
48. Trevelyan J., Needham E.W., and Smith S.C. Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain Am J Cardiol 93 2004 817 821
49. Dargie H. Myocardial infarction: redefined or reinvented? Heart 88 2002 1 3
50. Richards A.M., Lainchbury J.G., and Nicholls M.G. Unsatisfactory redefinition of myocardial infarction Lancet 357 2001 1635 1636
51. Bonaca M., Scirica B., and Sabatine M. Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I J Am Coll Cardiol 55 2010 2118 2124
52. Armstrong E.J., Morrow D.A., and Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines Circulation 113 2006 e72 5
53. Lagrand W.K., Visser C.A., and Hermens W.T. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100 1999 96 102
54. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention Am J Cardiol 92 2003 17K 22K
55. Podrez E.A., Schmitt D., and Hoff H.F. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro J Clin Invest 103 1999 1547 1560
56. Naruko T., Ueda M., and Haze K. Neutrophil infiltration of culprit lesions in acute coronary syndromes Circulation 106 2002 2894 2900
57. Buffon A., Biasucci L.M., and Liuzzo G. Widespread coronary inflammation in unstable angina N Engl J Med 347 2002 5 12
58. Sugiyama S., Okada Y., and Sukhova G.K. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am J Pathol 158 2001 879 891
59. Zhang R., Brennan M.L., and Fu X. Association between myeloperoxidase levels and risk of coronary artery disease Jama 286 2001 2136 2142
60. Ndrepepa G., Braun S., and Mehilli J. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 2008 90 96
61. Eggers K.M., Dellborg M., and Johnston N. Myeloperoxidase is not useful for the early assessment of patients with chest pain Clin Biochem 2009
62. Meuwese M.C., Stroes E.S., and Hazen S.L. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 50 2007 159 165
63. Baldus S., Heeschen C., and Meinertz T. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445
64. Mocatta T.J., Pilbrow A.P., and Cameron V.A. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J Am Coll Cardiol 49 2007 1993 2000
65. Morrow D.A., Sabatine M.S., and Brennan M.L. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J 29 2008 1096 1102
66. Brennan M.L., Penn M.S., and Van Lente F. Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604
67. Mitchell A.M., Garvey J.L., and Kline J.A. Multimarker panel to rule out acute coronary syndromes in low-risk patients Acad Emerg Med 13 2006 803 806
68. McCann C.J., Glover B.M., and Menown I.B. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain Adv Ther 26 2009 531 534
69. Shih J., Datwyler S.A., and Hsu S.C. Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations Clin Chem 54 2008 1076 1079
70. Baldus S., Rudolph V., and Roiss M. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase Circulation 113 2006 1871 1878
71. Struck J., Morgenthaler N.G., and Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients Peptides 26 2005 2500 2504
72. Mutlu G.M., and Factor P. Role of vasopressin in the management of septic shock Intensive Care Med 30 2004 1276 1291
73. Katan M., Morgenthaler N., and Widmer I. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level Neuro Endocrinol Lett 29 2008 341 346
74. Khan S.Q., Dhillon O.S., and O'Brien R.J. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 2007 2103 2110
75. Neuhold S., Huelsmann M., and Strunk G. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease J Am Coll Cardiol 52 2008 266 272
76. Voors A.A., von Haehling S., and Anker S.D. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study Eur Heart J 30 2009 1187 1194
77. Reichlin T., Hochholzer W., and Stelzig C. Incremental value of copeptin for rapid rule out of acute myocardial infarction J Am Coll Cardiol 54 2009 60 68
78. Keller T., Tzikas S., and Zeller T. Copeptin improves early diagnosis of acute myocardial infarction J Am Coll Cardiol 55 2010 2096 2106
79. Morgenthaler N.G., Struck J., and Alonso C. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112 119
80. de Kruif M.D., Lemaire L.C., and Giebelen I.A. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia Intensive Care Med 34 2008 518 522
81. Bhandari S.S., Loke I., and Davies J.E. Gender and renal function influence plasma levels of copeptin in healthy individuals Clin Sci (Lond) 116 2009 257 263
82. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
83. Bauskin A.R., Brown D.A., and Kuffner T. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer Cancer Res 66 2006 4983 4986
84. Ago T., and Sadoshima J. GDF15, a cardioprotective TGF-beta superfamily protein Circ Res 98 2006 294 297
85. Kempf T., Eden M., and Strelau J. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 2006 351 360
86. Xu J., Kimball T.R., and Lorenz J.N. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
87. Lind L., Wallentin L., and Kempf T. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study Eur Heart J 30 2009 2346 2353
88. Wollert K.C., Kempf T., and Peter T. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 2007 962 971
89. Khan S.Q., Ng K., and Dhillon O. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction Eur Heart J 30 2009 1057 1065
90. Eggers K.M., Kempf T., and Allhoff T. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur Heart J 29 2008 2327 2335
91. Wollert K.C., Kempf T., and Lagerqvist B. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 2007 1540 1548
92. Pope J.H., Aufderheide T.P., and Ruthazer R. Missed diagnoses of acute cardiac ischemia in the emergency department N Engl J Med 342 2000 1163 1170
93. Selker H.P., Beshansky J.R., and Griffith J.L. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial Ann Intern Med 129 1998 845 855
94. Heidenreich P.A., Alloggiamento T., and Melsop K. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis J Am Coll Cardiol 38 2001 478 485
95. Morrow D.A., and Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy Circulation 108 2003 250 252
96. Kontos M.C., Anderson F.P., and Hanbury C.M. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction Am J Emerg Med 15 1997 14 19
97. McCord J., Nowak R.M., and McCullough P.A. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 104 2001 1483 1488